Generate:Biomedicines Named One of Endpoint News 11 Most Promising Startups In 2022

In its annu­al award, End­points News hon­ored Generate:Biomedicines as one of the 2022 End­points 11 most promis­ing star­tups in biotech for 2022. This year’s pres­ti­gious award rec­og­nizes Generate’s poten­tial to bring new tech­nol­o­gy to bear in a rad­i­cal improve­ment of dis­cov­ery efficiency.”

The 2022 Endpoints 11 are private biotechs that are pushing the envelope with powerful new technology and defining the industry today. According to Endpoints News, each honoree has substantial resources, top talent and plans to tackle some of the biggest challenges in biotech. 

Generate and the other 2022 Endpoints 11 will be celebrated on the evening of Sept. 22 at the Boston Seaport. To watch the awards presentation, register for the event live stream here.